Consolidated Statement Of Cash Flows

ONO PHARMACEUTICAL CO., LTD. - Filing #7242262

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
50,047,000,000 JPY
50,047,000,000 JPY
119,000,000 JPY
50,166,000,000 JPY
127,977,000,000 JPY
127,977,000,000 JPY
128,040,000,000 JPY
62,000,000 JPY
Depreciation and amortization
26,894,000,000 JPY
18,140,000,000 JPY
Impairment losses (reversal of impairment losses)
7,981,000,000 JPY
14,885,000,000 JPY
Decrease (increase) in inventories
12,435,000,000 JPY
-3,420,000,000 JPY
Increase (decrease) in retirement benefit liability
-275,000,000 JPY
-22,000,000 JPY
Other
-4,870,000,000 JPY
197,000,000 JPY
Subtotal
124,446,000,000 JPY
164,517,000,000 JPY
Interest received
1,074,000,000 JPY
221,000,000 JPY
Dividends received
2,407,000,000 JPY
2,445,000,000 JPY
Interest paid
-1,408,000,000 JPY
-92,000,000 JPY
Income taxes paid
-44,060,000,000 JPY
-56,431,000,000 JPY
Net cash provided by (used in) operating activities
82,459,000,000 JPY
110,660,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-5,431,000,000 JPY
-4,020,000,000 JPY
Proceeds from sale of property, plant and equipment
9,000,000 JPY
903,000,000 JPY
Purchase of intangible assets
-2,559,000,000 JPY
-16,809,000,000 JPY
Payments for acquisition of subsidiaries
-364,816,000,000 JPY
JPY
Other
-752,000,000 JPY
-1,287,000,000 JPY
Net cash provided by (used in) investing activities
-136,785,000,000 JPY
48,077,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
150,000,000,000 JPY
JPY
Repayments of long-term borrowings
-15,000,000,000 JPY
JPY
Purchase of treasury shares
-1,000,000 JPY
-50,010,000,000 JPY
Dividends paid
-37,516,000,000 JPY
-37,183,000,000 JPY
Dividends paid to non-controlling interests
-11,000,000 JPY
-9,000,000 JPY
Net cash provided by (used in) financing activities
94,299,000,000 JPY
-89,848,000,000 JPY
Net increase (decrease) in cash and cash equivalents
39,974,000,000 JPY
68,889,000,000 JPY
Cash and cash equivalents
204,567,000,000 JPY
166,141,000,000 JPY
96,135,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
-1,548,000,000 JPY
1,116,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.